An investigation study of measuring the glycemic index (GI): non-randomized single administration study - An investigation study of measuring the glycemic index (GI)

ORTHOMEDICO Inc.0 个研究点目标入组 11 人2018年10月17日

适应症Healthy Japanese subjects

概览

阶段: 未知
干预措施: 未指定
疾病 / 适应症: Healthy Japanese subjects
发起方: ORTHOMEDICO Inc.
入组人数: 11
状态: 已完成
最后更新: 2年前

概览研究者入排标准结局指标相似试验

概览

简要总结

暂无简介。

注册库

who.int

开始日期

2018年10月17日

结束日期

2018年12月28日

最后更新

2年前

研究类型

Interventional

性别

All

研究者

发起方

ORTHOMEDICO Inc.

入排标准

入选标准

未提供

排除标准

•1\. Subjects who are undergoing medical treatment or have a medical history of malignant tumor, heart failure or myocardial infarction 2\. Subjects who have a pacemaker or an implantable cardioverter defibrillator (ICD) 3\. Currently undergoing treatment for any of the following chronic diseases: cardiac arrhythmia, liver disease, kidney disease, cerebrovascular disorder, rheumatism, diabetes mellitus, dyslipidemia, hypertension, or any other chronic diseases 4\. Subjects who have food allergies and/or food intolerances 5\. Subjects who take medications known to affect glucose tolerance 6\. Subjects who use insulin to treat diabetes or take antihyperglycemic drugs 7\. subjects who are the presence of disease or drugs which influence digestion and absorption of nutrients 8\. Subjects who use or take "Foods for Specified Health Uses", "Foods with Function Claims", or other functional food/beverage in daily 9\. Subjects who are currently taking medications (including herbal medicines) and dietary supplement. Particularly, the use of steroids, protease inhibitors, or antipsychotics 10\. Subjects who are an allergic reaction to medications and/or the test food related products. Particularly, the presence of celiac disease or sensitive to gluten 11\. Subjects who are pregnant, breast\-feeding, or planning to become pregnant 12\. Subjects who have a major medical or surgical event requiring hospitalization within the preceding 3 months 13\. Subjects who have been enrolled in other clinical trials within the last three months before the agreement to participate in this trial or plan to enroll in anther clinical trials during trial period 14\. Subjects who are judged as ineligible to participate in the study by the physician